ACCREDITATION STATEMENT
This activity is jointly provided by Medical Education Resources and the American Society of Diagnostic and Interventional Nephrology (ASDIN).
Target Audience:
This activity has been designed to meet the educational needs of dialysis access health care professionals involved in the care of patients with dialysis access, CKD, and ESKD.
Program Overview:
The ASDIN Annual Scientific Meeting is focused on the most up-to-date education in the field for both new and advanced dialysis practitioners. ASDIN seeks to offer the most current dialogue/education on issues facing interventionalists (nephrologists, interventional nephrologists, interventional radiologists, and vascular surgeons) in all practice settings. This year’s virtual offering will provide the most current information on dialysis access during a pandemic, literature update, interesting case discussions, tunneled dialysis catheters, peritoneal dialysis, ultrasound, research, percutaneous av fistula, surgical dialysis access procedures, disparity in dialysis access and dialysis access innovation. There will also be an Associate Session for nurses, techs, and administrators that focuses on implementation of KDOQI guidelines, the pandemic’s impact on vascular access practices, home dialysis, and percutaneous AVF.
Learning Outcome:
To improve knowledge and patient outcomes in the field of dialysis access.
Educational Objectives
ACCREDITATION
Physician Credit:
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources, Inc. (MER) and ASDIN. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit Designation:
Medical Education Resources designates this live activity for a maximum of 21.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21.50 (part II) MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Nursing Accreditation:
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 21.50 contact hours of continuing nursing education.
Provider approved by the California Board of Registered Nursing, Provider Number 12299, for 21.50 contact hours.
Disclosure of Conflicts of Interest:
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest. The faculty reported the following financial relationships with commercial interests who product or services may be mentioned in this activity::
Disclaimer:
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources or ASDIN. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
|
Print Page